- 101. Lung Myolipoma
- [A benign tumor of the lung composed of mature adipocytes and smooth muscle cells. ( NCI )] (UMLS (NCI) C1334451) Myolipoma of Lung;
Myolipoma of the Lung;
Pulmonary Myolipoma =Neoplastic Process | - 129. Lunula
- (UMLS (NCI) C0221991) =Body Part, Organ, or Organ Component
|
- 102. lung neoplasm
- [new abnormal tissue of the lung that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (CSP) C0024121) =Neoplastic Process ;
=Lung Diseases;
Neoplasm of Respiratory Tract =bronchial cancer;
Carcinoma, Non-Small-Cell Lung;
Carcinoma, Small Cell;
bronchial cancer;
Coin Lesion, Pulmonary;
Pancoast Syndrome;
Blastoma of Lung | - 130. Lupron
- (UMLS (NCI) C0701459) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 103. Lung Neuroendocrine Neoplasm
- (UMLS (NCI) C1334452) Lung Neuroendocrine Tumor;
Neuroendocrine Neoplasm of Lung;
Neuroendocrine Neoplasm of the Lung;
Neuroendocrine Tumor of Lung;
Neuroendocrine Tumor of the Lung;
Pulmonary Neuroendocrine Neoplasm;
Pulmonary Neuroendocrine Tumor =Neoplastic Process | - 131. Lupron Depot-Ped
- (UMLS (NCI) C0721462) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 104. Lung Non-Hodgkin Lymphoma
- (UMLS (NCI) C1334453) Lung Non-Hodgkin's Lymphoma;
Primary Lung Non-Hodgkin's Lymphoma;
=Neoplastic Process | - 132. LUPROSTIOL
- (UMLS (NCI) C0065258) =Eicosanoid; Pharmacologic Substance ;
|
- 105. Lung Non-Small Cell Carcinoma in situ
- [Stage 0 includes Tis,NO,MO. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. ( NCI )] (UMLS (NCI) C0278986) =Neoplastic Process
| - 133. lupus
- [A chronic inflammatory connective tissue disease marked by skin rashes, joint pain and swelling, inflammation of the kidneys, inflammation of the fibrous tissue surrounding the heart (i.e., the pericardium), as well as other problems. Not all affected individuals display all of these problems. Also called systemic lupus erythematosus. ( NCI )] (UMLS (NCI) C0409974) =Disease or Syndrome
|
- 106. LUNG OPERATION NEC
- [ ] (UMLS (ICD9CM) C0176526) =Therapeutic or Preventive Procedure
| - 134. Lupus Encephalitis
- (UMLS (NCI) C0740415) =Disease or Syndrome ;
|
- 107. Lung PAP-AD
- [A morphologic variant of lung adenocarcinoma characterized by the presence of papillary structures. (NCI05) ( NCI )] (UMLS (NCI) C1335325) Lung Papillary-Adenocarcinoma;
Papillary Adenocarcinoma of Lung;
Papillary Adenocarcinoma of the Lung;
Papillary Lung Adenocarcinoma;
=Neoplastic Process ;
| - 135. Lupus Glomerulonephritis
- [glomerulonephritis associated with systemic lupus erythematosus; classified into four histologic types: mesangial, focal, diffuse, and membranous. ( CSP )] (UMLS (NCI) C0024143) =Disease or Syndrome ;
=glomerulonephritis;
disseminated lupus erythematosus |
- 108. Lung Papilloma
- [A overgrowth of epithelial tissue in the respiratory tree. ( NCI )] (UMLS (NCI) C0281373) =Neoplastic Process ;
| - 136. lupus pernio
- [ ] (UMLS (CSP) C0024145) =Disease or Syndrome ;
|
- 109. Lung Parenchyma
- [Tissue consisting of an external serous coat, subserous areolar tissue and lung parenchyma. The parenchyma is made up of lobules wound together by connective tissue. A primary lobule consists of a terminal bronchiole, respiratory bronchioles, and alveolar ducts, which communicate with many alveoli, each alveolus being surrounded by a network of capillary blood vessels. ( NCI )] (UMLS (NCI) C0819757) Lung Tissue =Tissue
| - 137. Lurtotecan
- [An anticancer drug that belongs to the family of drugs called topoisomerase inhibitors. ( NCI )] (UMLS (NCI) C0293658) =Organic Chemical; Pharmacologic Substance ;
|
- 110. lung preservation
- [ ] (UMLS (CSP) C0599546) =Laboratory Procedure ;
| - 138. Lushootseed
- (UMLS (HL7) C1551948) =Language =CentralSalish;
|
- 111. lung pressure
- [ ] (UMLS (CSP) C0599321) =Organ or Tissue Function ;
| - 139. Luteal Cell Neoplasm
- [A benign ovarian stromal tumor in which more than 90% of the tumor cells resemble steroid hormone-secreting cells. Crystals of Reinke are not present. It occurs in post-menopausal women and it is usually associated with estrogenic effects. ( NCI )] (UMLS (NCI) C0024167) =Neoplastic Process ;
=Neoplasms, Gonadal Tissue;
Neoplasm of Ovary |
- 112. LUNG REPAIR NEC
- [ ] (UMLS (ICD9CM) C0176521) =Therapeutic or Preventive Procedure
| - 140. luteal phase
- [The period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION. ( MSH )] (UMLS (CSP) C0024153) =Organ or Tissue Function ;
|
- 113. Lung replaced by transplant
- [ ] (UMLS (ICD9CM) C0543420) =Finding
| - 141. Lutein Cell
- [The cells of the corpus luteum which are derived from the granulosa cells and the theca cells of the Graafian follicle. (MeSH) ( NCI )] (UMLS (NCI) C0024156) =Cell ;
|
- 114. Lung Right Upper Lobe
- (UMLS (NCI) C1261074) Upper Lobe of Right Lung -RUL;
Upper Lobe of the Right Lung;
Upper Lobe of the Right Lung -RUL =Body Part, Organ, or Organ Component | - 142. luteinization
- [Formation of CORPUS LUTEUM. This process includes capillary invasion of the ruptured OVARIAN FOLLICLE, hypertrophy of the GRANULOSA CELLS and the THECA CELLS, and the production of PROGESTERONE. Luteinization is regulated by LUTEINIZING HORMONE. ( MSH )] (UMLS (CSP) C0334024) =Organ or Tissue Function
|
- 115. Lung Sarcoidosis
- [Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431) ( MSH )] (UMLS (NCI) C0036205) =Disease or Syndrome ;
=Besnier Boeck disease;
ILD | - 143. Luteinized Ovarian Thecoma
- [A variant of ovarian thecoma characterized by the presence of lutein cells. It is associated with a lower frequency of estrogenic manifestations compared to typical thymomas. In a minority of cases androgenic manifestations are present. It may also be associated with sclerosing peritonitis which presents with ascites and symptoms of bowel obstruction. ( NCI )] (UMLS (NCI) C0334399) =Neoplastic Process
|
- 116. lung sarcoma
- [ ] (UMLS (CSP) C0598790) =Neoplastic Process ;
| - 144. luteolysis
- [Regression of ovarian corpora lutea. [http://ovary.stanford.edu] ( GO )] (UMLS (CSP) C0010096) =Organ or Tissue Function
|
- 117. Lung Sclerosing Angioma
- [A benign neoplasm of alveolar pneumocytes or ontogenetically primitive counterparts thereof. Morphological patterns that have been described include: solid, hemorrhagic, papillary, and sclerotic. Most lesions display a combination of two or three morphological patterns. Despite the implication by its name (HEMANGIOMA) of a vascular neoplasm, pulmonary sclerosing hemangioma is considered by most authorities to be an epithelial tumor. (Histopathology 2003;43(3):239-43; Arch Pathol Lab Med. 2001;125(10): 1335-9) ( MSH )] (UMLS (NCI) C1334455) Lung Sclerosing Hemangioma;
Pneumocytoma;
Sclerosing Angioma of Lung;
Sclerosing Angioma of the Lung;
Sclerosing Hemangioma of Lung;
Sclerosing Hemangioma of the Lung;
=Neoplastic Process | - 145. Luteovirus
- [A genus of plant viruses that infects both monocotyledonous and dicotyledonous plants. Its organisms are persistently transmitted by aphids, and weeds may provide reservoirs of infection. ( MSH )] (UMLS (CSP) C0206264) =Virus ;
|
- 118. Lung Solid Adenocarcinoma with Mucin
- [Amorphologic variant of lung adenocarcinoma characterized by a solid growth pattern and the presence of mucin producing neoplastic cells. (NCI05) ( NCI )] (UMLS (NCI) C1336026) Pulmonary Solid Adenocarcinoma with Mucin;
Solid Adenocarcinoma of Lung with Mucin;
Solid Adenocarcinoma of the Lung with Mucin;
Solid Carcinoma of Lung with Mucus Formation;
Solid Carcinoma of the Lung with Mucus Formation;
Solid Lung Adenocarcinoma with Mucin Production;
Solid Lung Carcinoma with Mucus Formation =Neoplastic Process ;
| - 146. Lutheran
- (UMLS (HL7) C0337738) =Idea or Concept =Religious Affiliation;
|
- 119. Lung Squamous Cell Carcinoma Stage II
- [Stage II includes: IIA: (T1, N1, M0); IIB: (T2, N2, M0); (T3, N0, M0). T2: Tumor with any of the following features of size or extent: More than 3cm in greatest dimension. Involves main bronchus, 2cm or more distal to the carina. Invades the visceral pleura. Associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: Tumor of any size that directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, mediastinal pleura, parietal pericardium; or tumor in the main bronchus less than 2cm distal to the carnia, but without involvement of the carnia; or associated atelectasis or obstructive pneumonitis of the entire lung. N0: No regional lymph node metastasis. N1: Metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes including involvement by direct extension of the primary tumor. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C0854992) Stage II Epidermoid Cell Carcinoma of Lung;
Stage II Epidermoid Cell Carcinoma of the Lung;
Stage II Epidermoid Cell Lung Carcinoma;
Stage II Squamous Cell Carcinoma of Lung;
Stage II Squamous Cell Carcinoma of the Lung;
Stage II Squamous Cell Lung Carcinoma =Neoplastic Process | - 147. Lutrin
- (UMLS (NCI) C1174770) =Organic Chemical; Pharmacologic Substance ;
|
- 120. Lung Squamous Cell Carcinoma Stage III
- [Stage III includes: IIIA: (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0) IIIB: ( Any T, N3, M0); (T4, Any N, M0) N1: regional metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes including involvement by direct extension of the primary tumor. N2: Metastasis to ipsilateral mediastinal and/or subcarinal lymph node(s). N3: Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s). T1: tumor is 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, and without bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: tumor has any of the following features of size or extent: more than 3 cm in greatest dimension; involves the main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: tumor (of any size) directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, mediastinal pleura, parietal pericardium; or tumor in the main bronchus less than 2 cm distal to the carina but without involvement of the carina; or associated atelectasis or obstructive pneumonitis of the entire lung. T4: tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, carina; or separate tumor nodules in the same lobe; or tumor with a malignant pleural effusion. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C0854993) Stage III Epidermoid Cell Carcinoma of Lung;
Stage III Epidermoid Cell Carcinoma of the Lung;
Stage III Epidermoid Cell Lung Carcinoma;
Stage III Squamous Cell Carcinoma of Lung;
Stage III Squamous Cell Carcinoma of the Lung;
Stage III Squamous Cell Lung Carcinoma =Neoplastic Process | - 148. Lutromone
- (UMLS (NCI) C0701115) =Steroid; Pharmacologic Substance; Hormone
|
- 121. Lung Surfactant
- [phospholipids secreted by the great alveolar cells into alveoli and respiratory air passages which contributes to the elastic property of pulmonary tissue. ( CSP )] (UMLS (NCI) C0034085) =Lipid; Pharmacologic Substance; Biologically Active Substance =Lipoprotein;
phosphatide;
Body System, Pulmonary;
=1,2-Dipalmitoylphosphatidylcholine;
beractant | - 149. Lutropin Alfa
- (UMLS (NCI) C1271607) Lutropin Alpha =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 122. Lung TAA
- [A tumor associated antigen derived from the cell surface antigen of lung cancer cells. Lung tumor associated antigen could be used as a diagnostic marker or as a form of immunotherapy targeted against lung cancer cells. ( NCI )] (UMLS (NCI) C0796687) Lung Tumor Associated Antigen;
tumor associated antigen, lung =Pharmacologic Substance; Immunologic Factor | - 150. Lutzomyia
- [ ] (UMLS (CSP) C0024175) =Invertebrate ;
|
- 123. lung tryptase
- [E.C. 3.4.21.59. ( CSP )] (UMLS (CSP) C0147080) =Amino Acid, Peptide, or Protein; Enzyme =Serine Endopeptidases;
| - 151. Luvox
- (UMLS (NCI) C0086307) =Organic Chemical; Pharmacologic Substance ;
|
- 124. Lung Upper Lobe
- [The lobe of the right lung that lies above the oblique and horizontal fissures and includes the apical, posterior and anterior bronchopulmonary segments; in the left lung, the lobe lies above the oblique fissure and contains the apicoposterior, anterior, superior lingular and inferior lingular segments. ( NCI )] (UMLS (NCI) C0225756) =Body Part, Organ, or Organ Component
| - 152. lux
- [The SI derived unit of illuminance equal to the direct illumination on a surface that is everywhere one meter from a uniform point source of one candela; a unit of illuminance that is equal to one lumen per square meter. ( NCI )] (UMLS (HL7) C0560137) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 125. lung visualization
- [ ] (UMLS (CSP) C0920570) =Diagnostic Procedure
| - 153. Luxabendazole
- (UMLS (NCI) C0065270) =Organic Chemical; Pharmacologic Substance ;
|
- 126. LUNG VOL REDUCTION SURG
- [ ] (UMLS (ICD9CM) C0375931) =Therapeutic or Preventive Procedure
| - 154. LUXATION OF GLOBE
- [ ] (UMLS (ICD9CM) C0154806) =Disease or Syndrome
|
- 127. lung volume
- [ ] (UMLS (CSP) C0231953) =Organ or Tissue Function
| - 155. Luxol fast blue with cresyl violet stain
- [Stain, Luxol fast blue with cresyl violet ( HL7V3.0 )] (UMLS (HL7) C1293988) =Laboratory Procedure =ObservationMethod;
|
- 128. lungfish
- [ ] (UMLS (CSP) C0599045) =Fish ;
| - 156. Luxol fast blue with Periodic acid-Schiff stain
- [Stain, Luxol fast blue with Periodic acid-Schiff ( HL7V3.0 )] (UMLS (HL7) C1293989) =Laboratory Procedure =ObservationMethod;
|
home
